# Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tocilizumab-for-treatment-of-severe-covid-19-patients-preliminary-results-from/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Marta Colaneri,Laura Bogliolo,Pietro Valsecchi,Paolo Sacchi,Valentina Zuccaro,Fabio Brandolino,Carlomaurizio Montecucco,Francesco Mojoli,Emanuele Maria Giusti,Raffaele Bruno,the COVID IRCCS San Matteo Pavia Task Force |
| Citations | 218 |
| DOI | 10.3390/microorganisms8050695 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.mdpi.com/2076-2607/8/5/695/pdf?version=1589016263 |
| OpenAlex ID | https://openalex.org/W3021859907 |
| PMID | 32397399 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Paolo Sacchi](https://scholariq.org/researchers/paolo-sacchi/)
- [Valentina Zuccaro](https://scholariq.org/researchers/valentina-zuccaro/)

## Paper primary topic

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Paper topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.